Intas Biopharmaceuticals Acquired 1 Company in 2006
life science Company

Intas Biopharmaceuticals has acquired 1 company.

Intas Biopharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Intas Biopharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

Intas Biopharmaceuticals Ltd.

Plot No. 423/P/A/GIDC Sarkhej - Bavla Highway Moraiya Taluka - Sanand District,
Ahemdabad, 382 210
India,
91 27 1766 0100
www.intasbiopharma.co.in/

Intas Biopharmaceuticals is a fully integrated biopharmaceuticals company manufacturing biotech and pharmaceutical products for oncology and other critical disorders. The company has one of the most comprehensive portfolios of oncology products, for solid tumors, hematological malignancies and supportive therapies.

M&A Summary

Buy vs Sell

Year ≤ '14 '15 '16 '17 '18 '19 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Life Science M&A - Last 3 Years

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 404 life science companies that have made at least 1 acquisition, 13 have acquired at least 5 companies, and 2 have acquired more than 10 companies.

The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 25 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is The Carlyle Group with 5 platform acquisitions.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.5K Private Equity Firms
  • 124K M&A Transactions
  • 134K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.